{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:21:43Z","timestamp":1792131703021,"version":"4.4.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>\n                    Huntington\u2019s disease (HD) is caused by an expansion of CAG trinucleotide repeat in the HTT gene; the exact pathogenesis of HD currently remains unclear. One of the promising directions in the study of HDs is to determine the molecular mechanism underlying the development and role of microRNAs (miRNAs). This study aimed to identify the profile of miRNAs in an HD human cell line model as diagnostic biomarkers for HD. To study HD, the human SH-SY5Y HD cell model is based on the expression of two different forms: pEGFP-Q23 and pEGFP-Q74 of HTT. The expression of Htt protein was confirmed using aggregation assays combined with immunofluorescence and Western blotting methods. miRNA levels were measured in SH-SY5Y neuronal cell model samples stably expressing Q23 and Q74 using the extraction-free HTG EdgeSeq protocol. A total of 2083 miRNAs were detected, and 354 (top 18 miRNAs) miRNAs were significantly differentially expressed (DE) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&amp;lt;\u20090.05) in Q23 and Q74 cell lines. A majority of the miRNAs were downregulated in the HD cell model. Moreover, we revealed that six DE miRNAs target seven genes (\n                    <jats:italic>ATN1, GEMIN4, EFNA5<\/jats:italic>\n                    ,\n                    <jats:italic>CSMD2, CREBBP, ATXN1,<\/jats:italic>\n                    and\n                    <jats:italic>B3GNT<\/jats:italic>\n                    ) that play important roles in neurodegenerative disorders and showed significant expression differences in mutant Htt (Q74) when compared to wild-type Htt (Q23) using RT-qPCR (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&amp;lt;\u20090.05 and 0.01). We demonstrated the most important DE miRNA-mRNA profiles, interaction binding sites, and their related pathways in HD using experimental and bioinformatics methods. This will allow the development of novel diagnostic strategies and provide alternative therapeutic routes for treating HD.\n                  <\/jats:p>","DOI":"10.3389\/fncel.2024.1399742","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T09:29:23Z","timestamp":1720603763000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Differential microRNA expression in the SH-SY5Y human cell model as potential biomarkers for Huntington\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Ayaz","family":"Belkozhayev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raigul","family":"Niyazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amjad","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoliy","family":"Ivashchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalidin","family":"Sharipov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"ref2","first-page":"161","article-title":"The role of MicroRNAs in human diseases","volume":"2","author":"Ardekani","year":"2010","journal-title":"Avic. J. Med. Biotechnol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1101\/gad.1630408","article-title":"Eph\/ephrin signaling: networks","volume":"22","author":"Arvanitis","year":"2008","journal-title":"Genes Dev."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/B978-0-444-51892-7.00032-2","article-title":"Spinocerebellar ataxia type 10","volume":"103","author":"Ashizawa","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbi.2016.11.026","article-title":"A genetic association study of CSMD1 and CSMD2 with cognitive function","volume":"61","author":"Athanasiu","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1523\/JNEUROSCI.3344-05.2006","article-title":"Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin Polyglutamine toxicity","volume":"26","author":"Bates","year":"2006","journal-title":"J. Neurosci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.2174\/1570159X19666210817150141","article-title":"Extracellular vesicles, stem cells and the role of miRNAs in neurodegeneration","volume":"20","author":"Belkozhayev","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/genes13050800","article-title":"Bioinformatics analysis of the interaction of miRNAs and piRNAs with human mRNA genes having di- and trinucleotide repeats","volume":"13","author":"Belkozhayev","year":"2022","journal-title":"Genes"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/ijms17060842","article-title":"MicroRNAs: key regulators in the central nervous system and their implication in neurological diseases","volume":"17","author":"Cao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1128\/MCB.20.5.1546-1552.2000","article-title":"Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation","volume":"20","author":"Cardinaux","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1083\/jcb.148.6.1177","article-title":"Gemin4","volume":"148","author":"Charroux","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12915-020-00886-1","article-title":"The CBP KIX domain regulates long-term memory and circadian activity","volume":"18","author":"Chatterjee","year":"2020","journal-title":"BMC Biol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40246-022-00404-0","article-title":"Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1","volume":"16","author":"Chen","year":"2022","journal-title":"Hum. Genom."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40035-022-00302-4","article-title":"Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer\u2019s disease","volume":"11","author":"Chen","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3233\/JHD-200433","article-title":"Approaches to sequence the HTT CAG repeat expansion and quantify repeat length variation","volume":"10","author":"Ciosi","year":"2021","journal-title":"J. Huntingtons Dis."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"705348","DOI":"10.3389\/fncel.2021.705348","article-title":"MicroRNAs in Huntington\u2019s disease: diagnostic biomarkers or therapeutic agents?","volume":"15","author":"Dong","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1160\/TH16-08-0643","article-title":"Bone morphogenetic protein 4 regulates microRNAs miR-494 and miR-126-5p in control of endothelial cell function in angiogenesis","volume":"117","author":"Esser","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.omtn.2018.01.007","article-title":"Supplemental treatment for Huntington\u2019s disease with miR-132 that is deficient in Huntington\u2019s disease brain","volume":"11","author":"Fukuoka","year":"2018","journal-title":"Mol. Therapy Nucleic Acids"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.3892\/mmr.2020.11347","article-title":"Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells","volume":"22","author":"Gao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.15190\/d.2014.26","article-title":"Key principles of miRNA involvement in human diseases","volume":"2","author":"Giza","year":"2014","journal-title":"Discover"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1038\/s41598-022-06970-6","article-title":"MicroRNA editing patterns in Huntington\u2019s disease","volume":"12","author":"Guo","year":"2022","journal-title":"Sci. Rep."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.21873\/anticanres.13148","article-title":"High miR-3687 expression affects migratory and invasive ability of Oesophageal carcinoma","volume":"39","author":"Hagio","year":"2019","journal-title":"Anticancer Res."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biopsych.2011.01.030","article-title":"The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia","volume":"70","author":"H\u00e5vik","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/bbrc.2000.3682","article-title":"Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded Polyglutamine tract: applying to quantification of protein components of the aggregates","volume":"277","author":"Hazeki","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/15257770.2019.1671592","article-title":"Limits of using oligonucleotides for allele-selective inhibition at trinucleotide repeat sequences \u2013 targeting the CAG repeat within ataxin-1","volume":"39","author":"Hu","year":"2020","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13105-010-0050-6","article-title":"Biological functions of microRNAs: a review","volume":"67","author":"Huang","year":"2011","journal-title":"J. Physiol. Biochem."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.6026\/97320630012237","article-title":"Prediction of miRNA binding sites in mRNA","volume":"12","author":"Ivashchenko","year":"2016","journal-title":"Bioinformation"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","article-title":"Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin","volume":"23","author":"Jiang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.omtn.2017.05.010","article-title":"Therapeutic suppression of miR-4261 attenuates colorectal Cancer by targeting MCC","volume":"8","author":"Jiao","year":"2017","journal-title":"Mol. Therapy Nucleic Acids"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fnmol.2017.00399","article-title":"Co-expression patterns between ATN1 and ATXN2 coincide with brain regions affected in Huntington\u2019s disease","volume":"10","author":"Keo","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/biom13050788","article-title":"Therapeutic strategies for spinocerebellar Ataxia type 1","volume":"13","author":"Kerkhof","year":"2023","journal-title":"Biomol. Ther."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/WCO.0000000000000959","article-title":"Ataxin-2 gene: a powerful modulator of neurological disorders","volume":"34","author":"Laffita-Mesa","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","article-title":"Altered microRNA regulation in Huntington\u2019s disease models","volume":"227","author":"Lee","year":"2011","journal-title":"Exp. Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1371\/journal.pgen.0030098","article-title":"A genomic pathway approach to a complex disease: axon guidance and Parkinson disease","volume":"3","author":"Lesnick","year":"2007","journal-title":"PLoS Genet."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1007\/s10620-018-5425-5","article-title":"Expression and localization of huntingtin-associated protein 1 (HAP1) in the human digestive system","volume":"64","author":"Li","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3892\/br.2014.278","article-title":"Maintenance of chaperone-mediated autophagy activity in cultured cells expressing mutant huntingtin","volume":"2","author":"Li","year":"2014","journal-title":"Biomed. Rep."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","article-title":"Distribution of miRNA expression across human tissues","volume":"44","author":"Ludwig","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1523\/JNEUROSCI.3037-17.2018","article-title":"miR126-5p downregulation facilitates axon degeneration and NMJ disruption via a non\u2013cell-autonomous mechanism in ALS","volume":"38","author":"Maimon","year":"2018","journal-title":"J. Neurosci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.4103\/1673-5374.310673","article-title":"Altered microRNA expression in animal models of Huntington\u2019s disease and potential therapeutic strategies","volume":"16","author":"Martinez","year":"2021","journal-title":"Neural Regen. Res."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.brainresrev.2005.02.001","article-title":"Functions of ephrin\/Eph interactions in the development of the nervous system: emphasis on the hippocampal system","volume":"49","author":"Mart\u00ednez","year":"2005","journal-title":"Brain Res. Rev."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"32409","DOI":"10.1242\/bio.032409","article-title":"Gemin4 is an essential gene in mice, and its overexpression in human cells causes relocalization of the SMN complex to the nucleoplasm","volume":"7","author":"Meier","year":"2018","journal-title":"Biol. Open"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1523\/JNEUROSCI.3001-05.2005","article-title":"CHIP suppresses Polyglutamine aggregation and toxicity in vitro and in vivo","volume":"25","author":"Miller","year":"2005","journal-title":"J. Neurosci."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.ymthe.2018.02.002","article-title":"Translation of MicroRNA-based huntingtin-lowering therapies from preclinical studies to the clinic","volume":"26","author":"Miniarikova","year":"2018","journal-title":"Mol. Ther."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and Atrophin-1 with CBP-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ajhg.2019.01.013","article-title":"De novo variants disrupting the HX repeat motif of ATN1 cause a recognizable non-progressive neurocognitive syndrome","volume":"104","author":"Palmer","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fnbeh.2020.00136","article-title":"miR-409 and miR-411 modulation in the adult brain of a rat model of depression and after fluoxetine treatment","volume":"14","author":"Patr\u00edcio","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/B978-0-444-63233-3.00009-9","article-title":"Repeat expansion diseases","volume":"147","author":"Paulson","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e6501","DOI":"10.1371\/journal.pone.0006501","article-title":"Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer\u2019s disease","volume":"4","author":"Potkin","year":"2009","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/hmg\/ddt350","article-title":"Transcriptome study of differential expression in schizophrenia","volume":"22","author":"Sanders","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1038\/s41598-022-09368-6","article-title":"Large-scale analysis of MicroRNA expression in motor neuron-like cells derived from human umbilical cord blood mesenchymal stem cells","volume":"12","author":"Sanooghi","year":"2022","journal-title":"Sci. Rep."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","article-title":"Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities","volume":"28","author":"Schmidt","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbrc.2010.05.007","article-title":"Altered microRNAs in STHdhQ111\/HdhQ111 cells: miR-146a targets TBP","volume":"396","author":"Sinha","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.omtm.2019.03.002","article-title":"AAV5-mi HTT gene therapy demonstrates sustained huntingtin lowering and functional improvement in Huntington disease mouse models","volume":"13","author":"Spronck","year":"2019","journal-title":"Mol. Therapy Methods Clin. Dev."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"8474","DOI":"10.18632\/oncotarget.3523","article-title":"MicroRNAs in apoptosis, autophagy and necroptosis","volume":"6","author":"Su","year":"2015","journal-title":"Oncotarget"},{"key":"ref57","first-page":"378","article-title":"Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy","volume":"4","author":"Suzuki","year":"2011","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12929-021-00755-1","article-title":"The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington\u2019s disease","volume":"28","author":"Tung","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4331\/wjbc.v1.i4.41","article-title":"MicroRNA: a matter of life or death","volume":"1","author":"Wang","year":"2010","journal-title":"World J. Biol. Chem."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12920-022-01335-4","article-title":"A novel CREBBP mutation and its phenotype in a case of Rubinstein-Taybi syndrome","volume":"15","author":"Wang","year":"2022","journal-title":"BMC Med. Genet."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2024.1399742\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T09:29:28Z","timestamp":1720603768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2024.1399742\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":60,"alternative-id":["10.3389\/fncel.2024.1399742"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2024.1399742","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"article-number":"1399742"}}